LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?
Fiche publication
Date publication
mars 2021
Journal
European journal of radiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HOEFFEL Christine
Tous les auteurs :
Barat M, Nguyen TTL, Hollande C, Coty JB, Hoeffel C, Terris B, Dohan A, Mallet V, Pol S, Soyer P
Lien Pubmed
Résumé
LI-RADS v2018 diagnostic system is used to diagnose hepatocellular carcinoma (HCC) in at risk patients. However, its applicability to HCC in non-alcoholic steatohepatitis (NASH) has not been specifically studied. The purpose of this study was to assess the applicability of LI-RADS v2018 diagnostic system for HCC in patients with NASH.
Mots clés
Carcinoma, hepatocellular (Unique ID, D006528), Liver neoplasms (Unique ID, D008113), Magnetic resonance imaging (Unique ID, D008279), Non-alcoholic fatty liver disease (Unique ID, D065626)
Référence
Eur J Radiol. 2021 Mar 11;138:109651